Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001422849-18-000078
Filing Date
2018-02-14
Accepted
2018-02-13 17:33:43
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G/A edgmrk.txt SC 13G/A 6787
  Complete submission text file 0001422849-18-000078.txt   8469
Mailing Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033
Business Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033 908-740-4000
Merck & Co., Inc. (Subject) CIK: 0000310158 (see all company filings)

EIN.: 221918501 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-33582 | Film No.: 18605228
SIC: 2834 Pharmaceutical Preparations

Mailing Address 333 SOUTH HOPE STREET 55TH FLOOR LOS ANGELES CA 90071
Business Address 333 SOUTH HOPE STREET 55TH FLOOR LOS ANGELES CA 90071 213-486-9200
Capital World Investors (Filed by) CIK: 0001422849 (see all company filings)

EIN.: 951411037 | State of Incorp.: DE | Fiscal Year End: 0630
Type: SC 13G/A